A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S. market presence.
Nyxoah secures $110M financing to accelerate U.S. launch of Genio
The financing includes $95M in equity funding and an expected $15M second tranche from the European Investment Bank loan. The funds will support the company’s next phase of U.S.-focused growth.
The company plans to accelerate adoption of Genio in the U.S., where it has already established a commercial team of 40 sales representatives. The device is designed to provide an innovative treatment option for OSA patients.
CEO Olivier Taelman
Last week’s tracker: Novanta, CeQur & more
Wise closes $34.8M Series D to support neurostim tech
WISE has closed an oversubscribed $34.8M (€30M) Series D financing round to accelerate development and clinical adoption of its Heron spinal cord stimulation system for chronic pain treatment.
The funding, which included participation from ENEA Tech and Biomedical as a strategic partner, will support Heron’s regulatory pathway, first-in-human study, and commercial expansion of WISE’s broader electrode portfolio.
CEO Luca Ravagnan
Sonire Therapeutics awarded $13M from Japanese government-backed innovation agency
Sonire Therapeutics has been awarded a $13M grant from Japan’s New Energy and Industrial Technology Development Organization to accelerate development of its Suizenji ultrasound-based treatment system for pancreatic cancer.
The funding will support manufacturing scale-up, regulatory activities in Japan, expansion into new clinical applications, and ongoing U.S. clinical development.
CEO Tohru Satoh
Icarus Medical secures $7.2M Series A to accelerate growth and innovation
The funding will support U.S. market expansion, product development, manufacturing growth, clinical validation, and team expansion.
Investors include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors.
CEO Dave Johnson
IceCure announces pricing of $5.5M Private Placement
The gross proceeds from the offering are expected to be approximately $5.5M, before deducting placement agent commissions and other estimated offering expenses.
The company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.
CEO Eyal Shamir
Endoscopic robotics company Channel Robotics raises $4.6M
Channel Robotics, a developer of a first-of-its-kind handheld endoscopic robotic platform, announced the successful close of a $2.5M Seed+ financing round led by True Ventures.
The financing brings the company’s total capital raised to $4.6M, supporting continued product development, regulatory advancement, and preparation for commercialization.
Co-Founder Michael Yip
June Health announces $2.4M funding round
Securian Canada contributed significantly to the funding as a strategic institutional investor, alongside AgeTech Capital and notable Canadian technology founders Dave and Mike Wessinger (PointClickCare) and Michael Garrity (Financeit), among others.
The funding will accelerate June Health’s mission to modernize how women access and experience healthcare through clinician-trained AI and integrated clinical support across every stage of life.
Founder and CEO Lori Casselman
